跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONCASPAR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ONCASPAR
Authorized
STANDARD
ONCASPAR
servier canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c0e60a1489b92f3e
Company
servier canada inc
Type
Standard
Approval Details
Approval Id
c0e60a1489b92f3e
Drug Approval Canada Name
ONCASPAR
Product Name
ONCASPAR
Status
Marketed
Status Date
2019-05-27
Original Market Date
2017-06-01
Din
02461900
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription , Schedule D
Ahfs
10:00.00
Atc Original
L01XX24 PEGASPARGASE
Atc Name
l 01 xx 24
Aig Number
0131872001
Company Name
servier canada inc
Company Address
270, 3224 Avenue Jean-Béraud, Laval, Quebec, Canada, H7T 2S4
Active Ingredients
PEGASPARGASE
750 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c0e60a1489b92f3e
Type
Standard
Back to Health Canada Approvals